Virtu Financial LLC Has $930,000 Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Virtu Financial LLC lifted its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 179.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,008 shares of the construction company’s stock after buying an additional 25,031 shares during the quarter. Virtu Financial LLC owned about 0.05% of Aspen Aerogels worth $930,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ASPN. American Century Companies Inc. grew its position in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares during the period. Hood River Capital Management LLC increased its position in Aspen Aerogels by 12.2% during the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after buying an additional 357,895 shares during the last quarter. Renaissance Technologies LLC acquired a new position in Aspen Aerogels during the second quarter worth approximately $8,340,000. Dimensional Fund Advisors LP raised its stake in Aspen Aerogels by 21.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock valued at $32,790,000 after buying an additional 240,921 shares during the period. Finally, Assenagon Asset Management S.A. boosted its stake in shares of Aspen Aerogels by 577.1% during the 2nd quarter. Assenagon Asset Management S.A. now owns 244,512 shares of the construction company’s stock worth $5,832,000 after acquiring an additional 208,398 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Trading Up 2.5 %

Shares of ASPN stock opened at $24.88 on Thursday. The stock has a 50 day simple moving average of $24.84 and a 200 day simple moving average of $23.09. Aspen Aerogels, Inc. has a 1 year low of $5.94 and a 1 year high of $33.15. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The stock has a market cap of $1.89 billion, a P/E ratio of -56.55 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. Aspen Aerogels’s quarterly revenue was up 144.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.22) EPS. On average, research analysts predict that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 4.30% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ASPN shares. B. Riley upgraded Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, June 25th. Craig Hallum raised their target price on shares of Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, June 14th. TD Cowen lifted their target price on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Benchmark reissued a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. Finally, Piper Sandler boosted their price objective on Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, May 29th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.70.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.